The effect of glycine and lisinopril on quality of life in women with hypertension and estrogen deficiency

DOI: https://doi.org/10.29296/25877305-2021-04-06
Download full text PDF
Issue: 
4
Year: 
2021

M. Khabibulina, Candidate of Medical Sciences; M. Shamilov Ural State Medical University,
Yekaterinburg

The impact of combination therapy with glycine and lisinopril (diroton) on quality of life (QOL) was studied in 77 patients with hypertension and reduced estradiol levels. The 36-Item Short Form Survey (SF-36) and the Hospital Anxiety and Depression Scale (HADS) were used to assess QOL. After combination therapy with glycine and lisinopril, the QOL in patients with hypertension and estrogen deficiency improved significantly (p
Keywords: 
cardiology
therapy
quality of life
anxiety
hypertension
estrogen deficiency
glycine
lisinopril

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Chazova I.E., Smetnik V.P., Balan V.E. Vedenie zhenschin s serdechno-sosudistym riskom v peri- i postmenopauze:konsensus rossijskih kardiologov i ginekologov. Consilium medicum. 2008; 10 (6): 5–18 [Chazova I.E., Smetnik V.P., Balan V.E. Vedenie zhenshchin s serdechno-sosudistym riskom v peri- i postmenopauze:konsensus rossiiskikh kardiologov i ginekologov. Consilium medicum. 2008; 10 (6): 5–18 (in Russ.)].
  2. Skornjakova M.N., Syrochkina M.A. Gipomenstrual'nyj sindrom. Rukovodstvo dlja vrachej. Ekaterinburg, 2008; 236 s. [Skornyakova M.N., Syrochkina M.A. Gipomenstrual’nyi sindrom. Rukovodstvo dlya vrachei. Ekaterinburg, 2008; 236 s. (in Russ.)].
  3. Shardin S.A. i dr. Serdechno-sosudistaja patologija u zhenschin. Ekaterinburg: Izd-vo Ural'skogo universiteta, 2007; s. 187 [Shardin S.A. et al. Serdechno-sosudistaya patologiya u zhenshchin. Ekaterinburg: Izd-vo Ural’skogo universiteta, 2007; s. 187 (in Russ.)].
  4. Habibulina M.M. Shamilov M.D. Kachestvo zhizni molodyh zhenschin s arterial'noj gipertenziej i izmenennym gormonal'nym fonom. Vrach. 2021; 32 (1): 46–9 [Khabibulina M., Shamilov M. Quality of life in young women with hypertension and an altered hormonal background. Vrach. 2021; 32 (1): 46–9 (in Russ.)]. https://doi.org/10.29296/25877305-2021-01-09
  5. Habibulina M.M. Psihovegetativnyj status i bezbolevaja ishemija miokarda v premenopauze pri metabolicheski zdorovom ozhirenii. Vrach. 2019; 30 (4): 79–83 [Khabibulina M. Psychoautonomic status and silent myocardial ischemia in premenopause in the presence of metabolically healthy obesity. Vrach. 2019; 30 (4): 79–83 (in Russ.)]. https://doi.org/10.29296/25877305-2019-04-15
  6. Palacios S., Berrego R. The importance of preventive health care in postmenopausal women. Maturitas. 2005; 52 (Supl. 1): 53–60. DOI: 10.1016/j.maturitas.2005.06.013
  7. Blumel J.E., Castello C. et al. Quality of life after the menopause – a population study. Maturitas. 2009; 34 (1): 17–23. DOI: 10.1016/s0378-5122(99)00081-x
  8. Habibulina M.M. Vlijanie gipoestrogenemii na kachestvo zhizni zhenschin s arterial'noj gipertoniej v period premenopauzy. Kardiologija. 2013; 53 (11): 45–8 [Khabibulina M.M. Effect of hypoestrogenemia on quality of life of premenopausal women with arterial hypertension. Kardiologiya. 2013; 53 (11): 45–8 (in Russ.)].
  9. Habibulina M.M., Dmitriev A.N., Fedorova N.N. Kachestvo zhizni molodyh zhenschin s arterial'noj gipertenziej s gipoestrogenemiej s «metabolicheski zdorovym» vistseral'nym ozhireniem. Evrazijskij Sojuz Uchenyh. 2017; 1 (34): 25–9 [Khabibulina M.M., Dmitriev A.N., Fedorova N.N. Kachestvo zhizni molodykh zhenshchin s arterial’noi gipertenziei s gipoestrogenemiei s «metabolicheski zdorovym» vistseral’nym ozhireniem. Evraziiskii Soyuz Uchenykh. 2017; 1 (34): 25–9 (in Russ.)].
  10. Habibulina M.M. Sravnitel'nyj analiz osobennostej serdechno-bolevogo sindroma i bezbolevaja ishemija miokarda u zhenschin s arterial'noj gipertenziej v period premenopauzy v zavisimosti ot sutochnogo profilja arterial'nogo davlenija. Kardiologija i serdechno-sosudistaja hirurgija. 2011; 4 (3): 55–60 [Khabibulina M.M. Comparative analysis of specifics of cardiac pain syndrome and silent myocardial ischemia in women with arterial hypertension in pre-menopause depending on daily profile of blood pressure. Kardiologiya i serdechno-sosudistaya khirurgiya. 2011; 4 (3): 55–60 (in Russ.)].
  11. Habibulina M.M. Terapija u zhenschin s arterial'noj gipertenziej i estrogenodefitsitom v pozdnem fertil'nom periode. Vrach. 2016; 4: 45–9 [Khabibulina M. Therapy in women with hypertension and estrogen deficiency in the late fertile period. Vrach. 2016; 4: 45–9 (in Russ.)].
  12. Habibulina M.M. Shamilov M.D. Bezbolevaja ishemija miokarda u molodyh zhenschin s kardialgiej, disgormonozom i razlichnoj komorbidnost'ju (serdechnoj i vneserdechnoj). Vrach. 2021; 32 (3): 61–5 [Khabibulina M., Shamilov M. Silent myocardial ischemia in young women with cardialgia, dyshormonosis, and various comorbidities (cardiac and extracardiac ones). Vrach. 2021; 32 (3): 61–5 (in Russ.)]. https://doi.org/10.29296/25877305-2021-03-11
  13. Rapeport N. Cardiovascular disease and hormone replacement therapy in post-menopausal women. Cardiovascular J S Afr. 2005; 16 (2): 76–80.
  14. Stein K.D., Jacobsen P.B. Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. J Pain Symptom. 2009; 19: 436–45.
  15. Kim M.-H., Kim H.-M., Jeong H.-J. Estrogen-like osteoprotective effects of glycine in in vitro and in vivo models of menopause. Amino Acids. 2016; 48 (3): 791–800. DOI: 10.1007/s00726-015-2127-6
  16. Casper R.F., Yen S.S. Neuroendocrinology of menopausal flushes: an hypothesis of flush mechanism. Clin Endocrinol (Oxford). 1985; 22 (3): 293–312. DOI: 10.1111/j.1365-2265.1985.tb03243.x
  17. Novik A.A., Ionova T.I. Rukovodstvo po issledovaniju kachestva zhizni v meditsine. SPb: Izdatel'skij dom «Neva», M.: «OLMA-PRESS Zvezdnyj mir», 2002; 320 s. [Novik A.A., Ionova T.I. Rukovodstvo po issledovaniyu kachestva zhizni v meditsine. SPb: Izdatel’skii dom «Neva», M.: «OLMA-PRESS Zvezdnyi mir», 2002; 320 s. (in Russ.)].
  18. Ware J.E. Measuring patients’ views: the optimum outcome measure. SF 36: a valid, reliable assessment of health from the patient’s point of view. BMJ. 1993; 306 (6890): 1429–30. DOI: 10.1136/bmj.306.6890.1429
  19. Ware J., Gandek B. Overview of the SF-36 Health Surveg and the International anality of Life Assessment (JQOLA). Projekt J Clin Epidemiol. 1998; 11: 903–12.
  20. The WHOQOL Group. What Quality of Life? The WHOQOL Group. World Health Forum. 1996; 17 (4): 354–6.
  21. Bardage C., Isacson D. hypertension and health – related quality of life – an epidemiological study in Sweden. J Clin Epidimiol. 2001; 54 (2): 172–81. DOI: 10.1016/s0895-4356(00)00293-6
  22. Roca-Cusachs A. Dalfo A. Relations between clinical and therapeutic variables and quality of life in hypertension. J Hypertens. 2001; 19 (10): 1913–9. DOI: 10.1097/00004872-200110000-00028
  23. Wang J., Kang D. Health – related quality of life in hypertensive patients. Zhonghya Yi Xue Za Zhi. 1999; 79 (8): 599–602.
  24. Klocer M. et al. Quality of life in patients with essential arterial hypertension. Part II – the effect of clinical factors. Przeql Lek. 2003; 60 (2): 101–6.